Lucid Diligence Brief: Shuttle Pharma x Molecule.ai LOI
Lucid Diligence Brief: Shuttle Pharma x Molecule.ai LOI Professional audiences…
Lucid Diligence Brief: Ascenta Capital Fund I, $325M final close
Lucid Diligence Brief: Ascenta Capital Fund I, $325M final close Professional…
Neuroscience Weekly News - October 8th 2025
🧠 This Week in Neuroscience: China’s Nerivio Nod, Ocrevus in Pediatric MS,…
Endocrinology Weekly Update - October 7th 2025
Endocrinology Update: Isturisa dosing model, YAP–T1D link, Mounjaro expansion…
Cardiovascular Weekly News - September 11th 2025
Cardiovascular Update: Verquvo Miss, CPAP Rethink, nsPFA IDE and More This…
Vaccines Weekly Update - September 5th 2025
🧬 This Week in Vaccine Research: FDA Clears Moderna, Varicella Vaccines,…
Rare Diseases Weekly News - September 4th 2025
🧬 This Week in Rare Diseases: FDA Approvals, Global Initiatives, and New…
Cardiovascular Weekly News - August 28th 2025
Cardiovascular Update: Renal Denervation Endorsed, Repatha Label Expands, 3D…
Immunology Weekly News - August 27th 2025
🔬 This week in Immunology Updates: A pivotal biosimilar launch, regulatory…
Neuroscience Weekly News - August 27th 2025
🧠 This Week in Neuroscience: AI-Redefined MS, $1B+ Epilepsy Deal, Home-Based…
Obesity Weekly News - August 26th 2025
Viking’s Crash, Orforglipron’s Rise, Semaglutide CV Data, SlimBiome Deal &…
Vaccines Weekly Update - August 22nd 2025
🧬 This Week in Vaccine Research: Cancer Vaccines, Exosome-Based Trials, Polio…